This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding
Clinical trial NCT03343704 · COMPLETED
Trial details
- NCT number
- NCT03343704
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2020-07-02
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.